Cargando…
The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy
The human gut microbiota has been identified as a possible novel risk factor for cardiovascular disease. The intestinal microbiome plays a role in the pathogenesis of atherosclerosis and heart failure. Even though studies in rodents suggested that gut microbes may affect the risk of heart disease, t...
Autores principales: | Forkosh, Esther, Ilan, Yaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519415/ https://www.ncbi.nlm.nih.gov/pubmed/31168383 http://dx.doi.org/10.1136/openhrt-2018-000993 |
Ejemplares similares
-
Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy
por: Forkosh, Esther, et al.
Publicado: (2020) -
Congestive heart failure
por: Zhao, Xuan
Publicado: (2019) -
Stem cell therapy for congestive heart failure
por: Gunduz, E, et al.
Publicado: (2011) -
Pacing in congestive heart failure
por: Morris-Thurgood, Jayne A, et al.
Publicado: (2000) -
Diagnostic accuracy of damage-associated molecular patterns (DAMPs) in patients with heart failure with a reduced ejection fraction
por: Hartupee, Justin, et al.
Publicado: (2017)